MedVi vs Maximus: Compare GLP-1 Programs & Pricing
Side-by-side MedVi and Maximus: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
MedVi and Maximus are two established telehealth providers offering GLP-1–based weight‑management programs. This article compares MedVi vs Maximus to help you identify which platform aligns best with your health goals, budget, and preferred level of clinical support.
MedVi vs Maximus: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| MedVi | $179.00 | $279.00 | $120 off first month (Code: ) | — No |
| Maximus | $132.99 | (Code: ) | — No |
MedVi vs Maximus: Medical Process & Accessibility
Both services operate completely online, eliminating the need for in‑person clinic visits. After you complete a digital health questionnaire, a board‑certified physician reviews your medical history, confirms eligibility, and issues a prescription for the selected GLP‑1 medication. MedVi emphasizes a rapid intake workflow, often delivering a prescription within 24‑48 hours, while Maximus incorporates a more structured onboarding sequence that includes a brief video consultation and a personalized treatment plan.
MedVi vs Maximus: Pricing Comparison
MedVi starts semaglutide at $179.00 per month and tirzepatide at $279.00 per month. Maximus does not currently list a semaglutide price, but offers tirzepatide at $132.99 per month, making it the lower price point for this medication. Both platforms advertise a first‑month discount – MedVi provides $120 off the first month, while Maximus presently has no public promotion.
Neither provider requires a recurring membership fee, which means the quoted drug cost is the primary expense you’ll see on your monthly statement. Shipping is typically included in the price, though some states may incur additional pharmacy fees. When budgeting, consider the total cost of the medication plus any optional lab work or virtual follow‑up appointments you may elect to add.
MedVi vs Maximus: Clinical Oversight & Support
Both companies employ licensed clinicians who monitor your progress, adjust dosages, and address side‑effects. MedVi’s support model leans toward asynchronous messaging, allowing you to send questions through a secure portal and receive responses within a business day. Maximus, on the other hand, offers scheduled video check‑ins every 4‑6 weeks, which can be valuable for patients who appreciate visual interaction and more frequent dose titration.
Book a Consultation with MedVi
MedVi vs Maximus: Medication Quality & Safety
Both providers partner with FDA‑registered compounding pharmacies located in the United States. The compounded semaglutide and tirzepatide are chemically identical to their branded counterparts (e.g., Wegovy® and Mounjaro®) and are prescribed under the supervision of a licensed prescriber, satisfying federal telehealth regulations. Patients receive a monthly supply in a discreet, temperature‑controlled package, with tamper‑evident seals to ensure product integrity.
MedVi vs Maximus: Customer Experience
Online reviews highlight MedVi’s strength in affordability and a swift onboarding timeline. Users frequently note that the platform’s streamlined questionnaire and quick prescription turnaround reduce the frustration often associated with traditional weight‑loss clinics. Maximus garners praise for its hands‑on clinical approach; patients appreciate the regular video visits, detailed progress tracking, and proactive outreach when side‑effects arise.
MedVi vs Maximus: Final Verdict
If your priority is a low‑cost entry point with minimal administrative steps, MedVi is the clear choice. The $179 starting price for semaglutide and the $120 first‑month discount make it especially attractive for price‑sensitive patients. Conversely, if you value ongoing clinical interaction, personalized dose adjustments, and a more structured follow‑up routine, Maximus may better suit your needs, particularly given its competitive tirzepatide price of $132.99 per month.
Both companies operate under U.S. telehealth laws, adhere to FDA‑mandated prescribing standards, and require a prescription from a board‑certified clinician before medication is dispensed. Ultimately, the decision hinges on whether you prioritize cost efficiency (MedVi) or a more intensive clinical partnership (Maximus).
Join MedVi
Get Started with Maximus
Disclaimer
This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.
Starts at $146/mo (6‑month plan)
- Affordable Semaglutide injections
- Klarna / AfterPay / Affirm supported
- Personalized dosing to reach goals
From $179 + free FedEx
- Approval within ~4 hours*
- Semaglutide & Tirzepatide available
- Price‑lock: same price any dose
Free consult ($75 value)
- GLP‑1 ID Protocol — 46% faster*
- 4.9★ Google & Trustpilot
- No‑obligation evaluation
$120 OFF First Month
- GLP‑1 meds delivered to your door
- Refund if you don’t lose weight
- Doctor‑approved, U.S. clinicians
Save $70 (Code: Explore)
- Ozempic®, Tirzepatide & Semaglutide
- Instant approval, ship ≤ 3 days
- No membership fees
From $155/mo (12‑month plan)
- No insurance or membership required
- Quick approval — no waitlist
- Brand & compounded available
$50 Off First Month
- 2‑minute quiz, $50 off month one
- Prescription in ≤ 24 hours
- Cancel or change anytime
Pay $199 first month
- Free overnight shipping
- Avg. 14% weight loss*
- No insurance needed
$120 OFF First Month
- Affordable access to treatments
- Doctor‑supervised programs
- Clear pricing
$50 OFF First Month
- Streamlined treatment process
- Holistic program
- Mobile‑friendly platform
.png)
Programs available
- 100% online evaluation
- Provider messaging & check‑ins
- Fast‑track programs
From $249 / month
- Certified GLP‑1 providers
- Licensed consultations
- Nationwide coverage